Literature DB >> 8178469

Disruption of the murine p53 gene by insertion of an endogenous retrovirus-like element (ETn) in a cell line from radiation-induced osteosarcoma.

K Mitreiter1, J Schmidt, A Luz, M J Atkinson, H Höfler, V Erfle, P G Strauss.   

Abstract

The mammalian genome harbors a large number of endogenous retroviruses and retrovirus-like elements. Increasing evidence is found that such elements can be activated and act as insertional mutagens. The activation of endogenous retroviral elements can be induced by a variety of environmental factors including irradiation. We have observed the insertion of a murine endogenous retrovirus-like ETn element into intro 4 of the p53 gene in an osteosarcoma cell line derived from a radiation-induced osteosarcoma. The insertion resulted in a p53-ETn-p53 fusion mRNA, a novel form of p53 mutation. This is the first report on insertion of an endogenous retroviral element into the p53 tumor suppressor gene. The data suggest that activated endogenous retroviruses and retrovirus-like elements might pose an enhanced risk for individuals exposed to noxae, which activate endogenous retroviral elements.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8178469     DOI: 10.1006/viro.1994.1253

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  3 in total

1.  Novel mouse type D endogenous proviruses and ETn elements share long terminal repeat and internal sequences.

Authors:  D L Mager; J D Freeman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Insertion of a retrotransposon in Mbp disrupts mRNA splicing and myelination in a new mutant rat.

Authors:  L T O'Connor; B D Goetz; J M Kwiecien; K H Delaney; A L Fletch; I D Duncan
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

3.  Tumour induction by methyl-nitroso-urea following preconceptional paternal contamination with plutonium-239.

Authors:  B I Lord; L B Woolford; L Wang; V A Stones; D McDonald; S A Lorimore; D Papworth; E G Wright; D Scott
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.